This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Amanat F., Stadlbauer D., Strohmeier S., Nguyen T.H., Chromikova V., McMahon M., Jiang K., Arunkumar G.A., Jurczyszak D., Polanco J., Bermudez-Gonzalez M., Kleiner G., Aydillo T., Miorin L., Fierer D., et al.: A serological assay to detect SARS-CoV-2 serocon-version in humans. Nat. Med., 2020; 26: 1033–1036AmanatF.StadlbauerD.StrohmeierS.NguyenT.H.ChromikovaV.McMahonM.JiangK.ArunkumarG.A.JurczyszakD.PolancoJ.Bermudez-GonzalezM.KleinerG.AydilloT.MiorinL.FiererD.A serological assay to detect SARS-CoV-2 serocon-version in humansNat. Med.2020261033103610.1038/s41591-020-0913-5Search in Google Scholar
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19. https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html (13.01.2021)AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html (13.01.2021)Search in Google Scholar
Baharoon S., Memish Z.A.: MERS-CoV as an emerging respiratory illness: A review of prevention methods. Travel. Med. Infect. Dis., 2019; 32: 101520BaharoonS.MemishZ.A.MERS-CoV as an emerging respiratory illness: A review of prevention methodsTravel. Med. Infect. Dis.20193210152010.1016/j.tmaid.2019.101520Search in Google Scholar
Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., Walmsley S.L., Mazzulli T., Avendano M., Derkach P., Ephtimios I.E., Kitai I., Mederski B.D., Shadowitz S.B., Gold W.L., et al.: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA, 2003; 289: 2801–2809BoothC.M.MatukasL.M.TomlinsonG.A.RachlisA.R.RoseD.B.DwoshH.A.WalmsleyS.L.MazzulliT.AvendanoM.DerkachP.EphtimiosI.E.KitaiI.MederskiB.D.ShadowitzS.B.GoldW.L.Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto areaJAMA20032892801280910.1001/jama.289.21.JOC30885Search in Google Scholar
Calina D., Docea A.O., Petrakis D., Egorow A.M., Ishmukhametov A.A., Gabibov A.G., Shtilman M.I., Kostoff R., Carvalho F., Vinceti M., Spandidos D.A., Tsatsakis A.: Towards effective COVID-19 vaccines: Updates, perspectives and challenges (review). Int. J. Mol. Med., 2020; 46: 3–16CalinaD.DoceaA.O.PetrakisD.EgorowA.M.IshmukhametovA.A.GabibovA.G.ShtilmanM.I.KostoffR.CarvalhoF.VincetiM.SpandidosD.A.TsatsakisA.Towards effective COVID-19 vaccines: Updates, perspectives and challenges (review)Int. J. Mol. Med.20204631610.3892/ijmm.2020.4596Search in Google Scholar
Calina D., Sarkar C., Arsene A.L., Salehi B., Docea A.O., Mondal M., Islam M.T., Zali A., Sharifi-Rad J.: Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development. Immunol. Res., 2020; 68: 315–324CalinaD.SarkarC.ArseneA.L.SalehiB.DoceaA.O.MondalM.IslamM.T.ZaliA.Sharifi-RadJ.Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines developmentImmunol. Res.20206831532410.1007/s12026-020-09154-4Search in Google Scholar
Callow K.A., Parry H.F., Sergeant M., Tyrrell D.A.: The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect., 1990; 105: 435–446CallowK.A.ParryH.F.SergeantM.TyrrellD.A.The time course of the immune response to experimental coronavirus infection of manEpidemiol. Infect.199010543544610.1017/S0950268800048019Search in Google Scholar
Cao W.C., Liu W., Zhang P.H., Zhang F., Richardus J.H.: Disappearance of antibodies to SARS-associated coronavirus after recovery. N. Engl. J. Med., 2007; 357: 1162–1163CaoW.C.LiuW.ZhangP.H.ZhangF.RichardusJ.H.Disappearance of antibodies to SARS-associated coronavirus after recoveryN. Engl. J. Med.20073571162116310.1056/NEJMc070348Search in Google Scholar
ClinicalTrials.gov. https://clinicaltrials.gov/ct2/results?cond=Covid19&term=vaccine&cntry=&state=&city=&dist= (15.10.2020)ClinicalTrials.govhttps://clinicaltrials.gov/ct2/results?cond=Covid19&term=vaccine&cntry=&state=&city=&dist= (15.10.2020)Search in Google Scholar
Corey L., Mascola J.R., Fauci A.S., Collins F.S.: A strategic approach to COVID-19 vaccine R&D. Science, 2020; 368: 948–950CoreyL.MascolaJ.R.FauciA.S.CollinsF.S.A strategic approach to COVID-19 vaccine R&DScience202036894895010.1126/science.abc5312Search in Google Scholar
Coronavirus. https://www.cdc.gov/coronavirus/types.html (15.10.2020)Coronavirushttps://www.cdc.gov/coronavirus/types.html (15.10.2020)Search in Google Scholar
DNA vaccines. https://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/vaccines-quality/dna (10.11.2020)DNA vaccineshttps://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/vaccines-quality/dna (10.11.2020)Search in Google Scholar
Draft landscape of COVID-19 candidate vaccines. WHO. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (15.10.2020)Draft landscape of COVID-19 candidate vaccinesWHOhttps://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (15.10.2020)Search in Google Scholar
Du Toit A.: Outbreak of a novel coronavirus. Nat. Rev. Microbiol., 2020; 18: 123Du ToitA.Outbreak of a novel coronavirusNat. Rev. Microbiol.20201812310.1038/s41579-020-0332-0Search in Google Scholar
EMA recommends COVID-19 vaccine Moderna for authorisation in the EU. https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-moderna-authorisation-eu (13.01.2021)EMA recommends COVID-19 vaccine Moderna for authorisation in the EUhttps://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-moderna-authorisation-eu (13.01.2021)Search in Google Scholar
Explaining operation warp speed. https://www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html (13.01.2021)Explaining operation warp speedhttps://www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html (13.01.2021)Search in Google Scholar
Folegatti P.M., Ewer K.J., Aley P.K., Angus B., Becker S., Belij-Rammerstorfer S., Bellamy D., Bibi S., Bittaye M., Clutterbuck E.A., Dold C., Faust S.N., Finn A., Flaxman A.L., Hallis B., et al.: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet, 2020; 396: 467–478FolegattiP.M.EwerK.J.AleyP.K.AngusB.BeckerS.Belij-RammerstorferS.BellamyD.BibiS.BittayeM.ClutterbuckE.A.DoldC.FaustS.N.FinnA.FlaxmanA.L.HallisB.Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trialLancet202039646747810.1016/S0140-6736(20)31604-4Search in Google Scholar
Ge H., Wang X., Yuan X., Xiao G., Wang C., Deng T., Yuan Q., Xiao X.: The epidemiology and clinical information about COVID-19. Eur. J. Clin. Microbiol. Infect. Dis., 2020; 39: 1011–1019GeH.WangX.YuanX.XiaoG.WangC.DengT.YuanQ.XiaoX.The epidemiology and clinical information about COVID-19Eur. J. Clin. Microbiol. Infect. Dis.2020391011101910.1007/s10096-020-03874-zSearch in Google Scholar
Graham B.S.: Rapid COVID-19 vaccine development. Science, 2020; 368: 945–946GrahamB.S.Rapid COVID-19 vaccine developmentScience202036894594610.1126/science.abb8923Search in Google Scholar
Guarner J.: Three emerging coronaviruses in two decades. The story of SARS, MERS, and now COVID-19. Am. J. Clin. Pathol., 2020; 153: 420–421GuarnerJ.Three emerging coronaviruses in two decades. The story of SARS, MERS, and now COVID-19Am. J. Clin. Pathol.202015342042110.1093/ajcp/aqaa029Search in Google Scholar
Hasson S.S., Al-Busaidi J.K., Sallam T.A.: The past, current and future trends in DNA vaccine immunisations. Asian Pac. J. Trop. Biomed., 2015; 5: 344–353HassonS.S.Al-BusaidiJ.K.SallamT.A.The past, current and future trends in DNA vaccine immunisationsAsian Pac. J. Trop. Biomed.2015534435310.1016/S2221-1691(15)30366-XSearch in Google Scholar
Hsu L.Y., Lee C.C., Green J.A., Ang B., Paton N.I., Lee L., Villacian J.S., Lim P.L., Earnest A., Leo Y.S.: Severe acute respiratory syndrome (SARS) in Singapore: Clinical features of index patient and initial contacts. Emerg. Infect. Dis., 2003; 9: 713–717HsuL.Y.LeeC.C.GreenJ.A.AngB.PatonN.I.LeeL.VillacianJ.S.LimP.L.EarnestA.LeoY.S.Severe acute respiratory syndrome (SARS) in Singapore: Clinical features of index patient and initial contactsEmerg. Infect. Dis.2003971371710.3201/eid0906.030264Search in Google Scholar
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395: 497–506HuangC.WangY.LiX.RenL.ZhaoJ.HuY.ZhangL.FanG.XuJ.GuX.ChengZ.YuT.XiaJ.WeiY.WuW.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet202039549750610.1016/S0140-6736(20)30183-5Search in Google Scholar
Huang L., Rong Y., Pan Q., Yi K., Tang X., Zhang Q., Wang W., Wu J., Wanga F.: SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies. Asian J. Pharm. Sci., 2020; doi: 10.1016/j.ajps.2020.08.001HuangL.RongY.PanQ.YiK.TangX.ZhangQ.WangW.WuJ.WangaF.SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategiesAsian J. Pharm. Sci.202010.1016/j.ajps.2020.08.001746262932905011Open DOISearch in Google Scholar
Hui D.S., Zumla A.: Severe acute respiratory syndrome (SARS): Epidemiology and clinical features. Postgrad. Med. J., 2004; 80: 373–381HuiD.S.ZumlaA.Severe acute respiratory syndrome (SARS): Epidemiology and clinical featuresPostgrad. Med. J.20048037338110.1136/pgmj.2004.020263174305415254300Search in Google Scholar
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html (13.01.2021)Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United Stateshttps://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html (13.01.2021)Search in Google Scholar
Jackson L.A., Anderson E.J., Rouphael N.G., Roberts P.C., Makhene M., Coler R.N., McCullough M.P., Chappell J.D., Denison M.R., Stevens L.J., Pruijssers A.J., McDermott A., Flach B., Doria-Rose N.A., et al.: An mRNA vaccine against SARS-CoV-2 – preliminary report. N. Engl. J. Med., 2020; 383: 1920–1931JacksonL.A.AndersonE.J.RouphaelN.G.RobertsP.C.MakheneM.ColerR.N.McCulloughM.P.ChappellJ.D.DenisonM.R.StevensL.J.PruijssersA.J.McDermottA.FlachB.Doria-RoseN.A.An mRNA vaccine against SARS-CoV-2 – preliminary reportN. Engl. J. Med.20203831920193110.1056/NEJMoa2022483737725832663912Search in Google Scholar
Jeyanathan M., Afkhami S., Smaill F., Miller M.S., Lichty B.D., Xing Z.: Immunological considerations for COVID-19 vaccine strategies. Nat. Rev. Immunol., 2020; 20: 615–632JeyanathanM.AfkhamiS.SmaillF.MillerM.S.LichtyB.D.XingZ.Immunological considerations for COVID-19 vaccine strategiesNat. Rev. Immunol.20202061563210.1038/s41577-020-00434-6747268232887954Search in Google Scholar
Ki M.: 2015 MERS outbreak in Korea: Hospital-to-hospital transmission. Epidemiol. Health, 2015; 37: e2015033KiM.2015 MERS outbreak in Korea: Hospital-to-hospital transmissionEpidemiol. Health201537e201503310.4178/epih/e2015033Search in Google Scholar
Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., et al.: Genomic characterization and epidemiology of 2019 novel corona-virus: Implications for virus origins and receptor binding. Lancet, 2020; 395: 565–574LuR.ZhaoX.LiJ.NiuP.YangB.WuH.WangW.SongH.HuangB.ZhuN.BiY.MaX.ZhanF.WangL.HuT.Genomic characterization and epidemiology of 2019 novel corona-virus: Implications for virus origins and receptor bindingLancet202039556557410.1016/S0140-6736(20)30251-8Search in Google Scholar
Mao R., Qiu Y., He J.S., Tan J.Y., Li X.H., Liang J., Shen J., Zhu L.R., Chen Y., Iacucci M., Ng S.C., Ghosh S., Chen M.H.: Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol., 2020; 5: 667–678MaoR.QiuY.HeJ.S.TanJ.Y.LiX.H.LiangJ.ShenJ.ZhuL.R.ChenY.IacucciM.NgS.C.GhoshS.ChenM.H.Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: A systematic review and meta-analysisLancet Gastroenterol. Hepatol.2020566767810.1016/S2468-1253(20)30126-6Search in Google Scholar
Masters P.S.: The molecular biology of coronaviruses. Adv. Virus Res., 2006; 66: 193–292MastersP.S.The molecular biology of coronavirusesAdv. Virus Res.20066619329210.1016/S0065-3527(06)66005-3Search in Google Scholar
McBride R., van Zyl M., Fielding B.C.: The coronavirus nucleocapsid is a multifunctional protein. Viruses, 2014; 6: 2991–3018McBrideR.van ZylM.FieldingB.C.The coronavirus nucleocapsid is a multifunctional proteinViruses201462991301810.3390/v6082991Search in Google Scholar
Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (15.10.2020)Middle East respiratory syndrome coronavirus (MERS-CoV)https://www.who.int/emergencies/mers-cov/en/ (15.10.2020)Search in Google Scholar
Moderna COVID-19 vaccine. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine (13.01.2021)Moderna COVID-19 vaccinehttps://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine (13.01.2021)Search in Google Scholar
Mullard A.: COVID-19 vaccine development pipeline gears up. Lancet, 2020; 395: 1751–1752MullardA.COVID-19 vaccine development pipeline gears upLancet20203951751175210.1016/S0140-6736(20)31252-6Search in Google Scholar
Mullol J., Alobid I., Mariño-Sánchez F., Izquierdo-Domínguez A., Marin C., Klimek L., Wang D.Y., Liu Z.: The loss of smell and taste in the COVID-19 outbreak: A tale of many countries. Curr. Allergy Asthma Rep., 2020; 20: 61MullolJ.AlobidI.Mariño-SánchezF.Izquierdo-DomínguezA.MarinC.KlimekL.WangD.Y.LiuZ.The loss of smell and taste in the COVID-19 outbreak: A tale of many countriesCurr. Allergy Asthma Rep.2020206110.1007/s11882-020-00961-1739745332748211Search in Google Scholar
Neuman B.W., Kiss G., Kunding A.H., Bhella D., Baksh M.F., Connelly S., Droese B., Klaus J.P., Makino S., Sawicki S.G., Siddell S.G., Stamou D.G., Wilson I.A., Kuhn P., Buchmeier M.J.: A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol., 2011; 174: 11–22NeumanB.W.KissG.KundingA.H.BhellaD.BakshM.F.ConnellyS.DroeseB.KlausJ.P.MakinoS.SawickiS.G.SiddellS.G.StamouD.G.WilsonI.A.KuhnP.BuchmeierM.J.A structural analysis of M protein in coronavirus assembly and morphologyJ. Struct. Biol.2011174112210.1016/j.jsb.2010.11.021448606121130884Search in Google Scholar
Padron-Regalado E.: Vaccines for SARS-CoV-2: Lessons from other coronavirus strains. Infect. Dis. Ther., 2020; 9: 255–274Padron-RegaladoE.Vaccines for SARS-CoV-2: Lessons from other coronavirus strainsInfect. Dis. Ther.2020925527410.1007/s40121-020-00300-x717704832328406Search in Google Scholar
Pardi N., Hogan M.J., Porter F.W., Weissman D.: mRNA vaccines – a new era in vaccinology. Nat. Rev. Drug Discov., 2018; 17: 261–279PardiN.HoganM.J.PorterF.W.WeissmanD.mRNA vaccines – a new era in vaccinologyNat. Rev. Drug Discov.20181726127910.1038/nrd.2017.243590679929326426Search in Google Scholar
Peeples L.: News feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proc. Natl. Acad. Sci. USA, 2020; 117: 8218–8221PeeplesL.News feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccineProc. Natl. Acad. Sci. USA20201178218822110.1073/pnas.2005456117716547032229574Search in Google Scholar
Peiris J.S.: Coronaviruses. In: Medical microbiology, ed.: D. Greenwood, M. Barer, R. Slack, W. Irving. Churchill Livingstone, Edinburgh 2012, 587–593PeirisJ.S.CoronavirusesIn:Medical microbiologyed.:GreenwoodD.BarerM.SlackR.IrvingW.Churchill LivingstoneEdinburgh201258759310.1016/B978-0-7020-4089-4.00072-XSearch in Google Scholar
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against (09.11.2020)Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 studyhttps://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against (09.11.2020)Search in Google Scholar
Project Lightspeed. https://biontech.de/covid-19-portal/project-lightspeed (13.01.2021)Project Lightspeedhttps://biontech.de/covid-19-portal/project-lightspeed (13.01.2021)Search in Google Scholar
Romano M., Ruggiero A., Squeglia F., Maga G., Berisio R.: A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells, 2020; 9: 1267RomanoM.RuggieroA.SquegliaF.MagaG.BerisioR.A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final cappingCells20209126710.3390/cells9051267729102632443810Search in Google Scholar
Ruch T.R., Machamer C.E.: The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus. J. Virol., 2011; 85: 675–685RuchT.R.MachamerC.E.The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virusJ. Virol.20118567568510.1128/JVI.01570-10302003221047962Search in Google Scholar
SARS (Severe acute respiratory syndrome). https://www.who.int/ith/diseases/sars/en/ (15.10.2020)SARS (Severe acute respiratory syndrome)https://www.who.int/ith/diseases/sars/en/ (15.10.2020)Search in Google Scholar
Satarker S., Nampoothiri M.: Structural proteins in severe acute respiratory syndrome coronavirus-2. Arch. Med. Res., 2020; 51: 482–491SatarkerS.NampoothiriM.Structural proteins in severe acute respiratory syndrome coronavirus-2Arch. Med. Res.20205148249110.1016/j.arcmed.2020.05.012724749932493627Search in Google Scholar
Schoeman D., Fielding B.C.: Coronavirus envelope protein: Current knowledge. Virol. J., 2019; 16: 69SchoemanD.FieldingB.C.Coronavirus envelope protein: Current knowledgeVirol. J.2019166910.1186/s12985-019-1182-0653727931133031Search in Google Scholar
Sorbello M., El-Boghdadly K., Di Giacinto I., Cataldo R., Esposito C., Falcetta S., Merli G., Cortese G., Corso R.M., Bressan F., Pintaudi S., Greif R., Donati A., Petrini F.: The Italian coronavirus disease 2019 outbreak: Recommendations from clinical practice. Anaesthesia, 2020; 75: 724–732SorbelloM.El-BoghdadlyK.Di GiacintoI.CataldoR.EspositoC.FalcettaS.MerliG.CorteseG.CorsoR.M.BressanF.PintaudiS.GreifR.DonatiA.PetriniF.The Italian coronavirus disease 2019 outbreak: Recommendations from clinical practiceAnaesthesia20207572473210.1111/anae.1504932221973Search in Google Scholar
Sternberg A., Naujokat C.: Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination. Life Sci., 2020; 257: 118056SternbergA.NaujokatC.Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccinationLife Sci.202025711805610.1016/j.lfs.2020.118056733613032645344Search in Google Scholar
Su S., Wong G., Shi W., Liu J., Lai A.C., Zhou J., Liu W., Bi Y., Gao G.F.: Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol., 2016; 24: 490–502SuS.WongG.ShiW.LiuJ.LaiA.C.ZhouJ.LiuW.BiY.GaoG.F.Epidemiology, genetic recombination, and pathogenesis of coronavirusesTrends Microbiol.20162449050210.1016/j.tim.2016.03.003712551127012512Search in Google Scholar
Tao Y., Shi M., Chommanard C., Queen K., Zhang J., Markotter W., Kuzmin I.V., Holmes E.C., Tong S.: Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history. J. Virol., 2017; 91: e01953–16TaoY.ShiM.ChommanardC.QueenK.ZhangJ.MarkotterW.KuzminI.V.HolmesE.C.TongS.Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination historyJ. Virol.201791e019531610.1128/JVI.01953-16530995828077633Search in Google Scholar
Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z.: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020; 323: 1061–1069WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.WangB.XiangH.ChengZ.XiongY.ZhaoY.LiY.WangX.PengZ.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, ChinaJAMA20203231061106910.1001/jama.2020.1585704288132031570Search in Google Scholar
Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., et al.: A pneumonia outbreak associated with a new corona-virus of probable bat origin. Nature, 2020; 579: 270–273ZhouP.YangX.L.WangX.G.HuB.ZhangL.ZhangW.SiH.R.ZhuY.LiB.HuangC.L.ChenH.D.ChenJ.LuoY.GuoH.JiangR.D.A pneumonia outbreak associated with a new corona-virus of probable bat originNature202057927027310.1038/s41586-020-2012-7709541832015507Search in Google Scholar